The case for adjuvant chemotherapy in pancreatic cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 2, 2006, Pages 383-401

  Ghaneh, Paula ^a   Sultana, Asma ^a   Shore, Susannah ^a   Stocken, Deborah ^a   Neoptolemos, John ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Meta analysis; Pancreatic cancer; Randomised controlled trial

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; MITOXANTRONE;

ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LONG TERM CARE; LYMPH NODE METASTASIS; META ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; HUMANS; PANCREATIC NEOPLASMS;

EID: 33645028319     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2005.11.008     Document Type: Article

References (36)

1. http://www.iarc.fr/
2. S.R. Bramhall W.H. Allum A.G. Jones et. al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study Br J Surg 82 1995 111-115
3. J. Neoptolemos R.C.G. Russell S.R. Bramhall B. Theis Low mortality following resection for pancreatic and periampullary tumours in 1026 patients Br J Surg 84 1997 1370-1376
4. N. Alexakis C. Halloran M. Raraty et. al. Current standards of surgery for pancreatic cancer Br J Surg 91 2004 1410-1427
5. S. Pedrazzoli V. Dicarlo R. Dionigi et. al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group Ann Surg 228 1998 508-517
6. C.J. Yeo J.L. Cameron K.D. Lillemoe et. al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, Part 2: Randomized control trial evaluating survival, morbidity, and mortality Ann Surg 236 2002 355-368
7. F. Spitz J. Abbruzzese J. Lee et. al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 10 1997 3291-3293
8. Palmer D, Stocken D, Buckels J, et al. A randomised phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: gemcitabine alone vs. gemcitabine combined with cisplatin. ASCO annual meeting proceedings (post-meeting edition); 2004. p. 4215.
9. O. Ishikawa H. Ohigashi Y. Sasaki et. al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas Am J Surg 168 4 1994 361-364
10. H. Ozaki T. Kinoshita T. Kosuge et. al. Effectiveness of multimodality treatment for resectable pancreatic cancer Int J Pancreatol 7 1990 195-200
11. K. Link A. Formentini F. Gansauge et. al. Regional coeliac artery infusion as adjuvant treatment after pancreatic cancer resection Digestion 58 6 1997 529-532
12. O. Ishikawa H. Ohigashi S. Imaoka et. al. Regional chemotherapy to prevent hepatic metastases after resection of pancreatic cancer Hepatogastroenterology 44 18 1997 1541-1546
13. H. Beger F. Gansauge M. Buchler K. Link Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurence of liver metastases World J Surg 23 1999 946-949
14. H. Ozaki T. Kinoshita T. Kosuge et. al. Long-term survival after multimodality treatment for resectable pancreatic cancer Int J Pancreatol 27 3 2000 217-224
15. E. Papachristou K. Link M. Schoenberg Regional coeliac artery infusion in the adjuvant treatment of pancreatic cancer Anticancer Res 23 2A 2003 831-834
16. P. Ghaneh J.P. Neoptolemos Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer Surg Oncol Clin N Am 13 2004 567-587
17. W. Sindelar T. Kinsella Randomised trial of intraoperative radiotherapy in resected carcinoma of the pancreas Int J Radiat Oncol Biol Phys 12 supplement 1 1986 148
18. M. Imamura R. Doi T. Imaizumi et. al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer Surgery 136 2004 1003-1011
19. J. Klinkenbijl J. Jeekel T. Sahmoud et. al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 6 1999 776-784
20. J. Neoptolemos J. Dunn D. Stocken et. al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial Lancet 358 9293 2001 1576-1585
21. J. Neoptolemos D. Stocken H. Freiss et. al. A randomised trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200-1210
22. M. Kalser S. Ellenberg Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899-903
23. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer: Gastrointestinal Tumor Study Group. Cancer 1987;59:2006-10.
24. C. Yeo R. Abrams L. Grochow et. al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival: A prospective, single-institution experience Ann Surg 225 5 1997 621-636
25. L. Kachnic J. Shaw M. Manning et. al. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas Int J Cancer 96 2001 132-139
26. J. Laethem A. Demols F. Gay et. al. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: A phase II study Int J Radiat Oncol Biol Phys 56 4 2003 974-980
27. R. Wilkowski M. Thoma E. Duhmke et. al. Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma Int J Radiat Oncol Biol Phys 58 3 2004 768-772
28. K. Bakkevold B. Arnesjo O. Dahl B. Kambestad Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicentre study Eur J Cancer 29A 5 1993 698-703
29. T. Takada H. Amano H. Yasuda et. al. Is postoperative adjuvant chemotherapy useful for gall bladder carcinoma? A phase III multicentre prospective randomised controlled trial in patients with resected pancreaticobiliary carcinoma Cancer 95 8 2002 1685-1695
30. Neuhaus P, Oettle H, Post S, et al. A randomised, prospective, multicentre, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer. ASCO 2005, Orlando.
31. I. Kurosaki K. Hatakeyama The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer Hepatogastroenterology 51 57 2004 634-637
32. T. Splinter H. Obertop T. Kok J. Jeekel Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and head of pancreas. A non-randomised pilot study J Cancer Res Clin 115 1989 200-202
33. H. Baumel M. Huguier J. Manderscheid et. al. Results of resection for cancer of exocrine pancreas: A study from the French Association of Surgeons Br J Surg 81 1994 102-107
34. D. Stocken M. Buchler C. Dervenis et. al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer 92 2005 1372-1381
35. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. ASCO 2005 [abstract].
36. D. Cunningham I. Chau D. Stocken et. al. Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer Eur J Cancer 3 supplement 2005 4